Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Industry Applauds FDA Draft Guidance On Mobile Medical Apps

This article was originally published in The Gray Sheet

Executive Summary

The medical device and software industries voiced support last week for a July 19 FDA draft guidance that helps clarify the types of mobile software applications that would face FDA regulation.

Related Content

FDA Mobile Health Policy Proposal Draws Fire From Far And Wide
FDA Urged To Articulate Policy On Clinical Decision Support Software
FDA Urged To Create mHealth Regulatory Office
Digital Health In Brief
New Rules Needed To Classify mHealth Products, Says Industry Coalition
FDA Wants Mobile App Guidance To Connect With Device-Reg-Naïve Developers
Regulatory News In Brief
Mobile Devices Bridging Accessibility Gap In Rural Areas, Report Says
mHealth Innovators Seek Access To More Wireless Spectrum
Mobile Health Device Field Seeks Regulatory Guidance From FDA And FCC





Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts